Samantha Meltzer-Brody Selected Research

Postpartum Depression (Post-Natal Depression)

3/2022	App-Based Ecological Momentary Assessment to Enhance Clinical Care for Postpartum Depression: Pilot Acceptability Study.
1/2022	Transcriptome-wide association study for postpartum depression implicates altered B-cell activation and insulin resistance.
1/2022	Interpersonal therapy versus antidepressant medication for treatment of postpartum depression and anxiety among women with HIV in Zambia: a randomized feasibility trial.
1/2022	A Brexanolone Treatment Program at an Academic Medical Center: Patient Selection, 90-Day Posttreatment Outcomes, and Lessons Learned.
1/2021	Genome-wide gene expression changes in postpartum depression point towards an altered immune landscape.
1/2021	Brexanolone in Postpartum Depression: Post Hoc Analyses to Help Inform Clinical Decision-Making.
1/2021	Achieving clinical response in postpartum depression leads to improvement in health-related quality of life.
1/2021	Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial.
10/2020	Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for Depression.
5/2020	Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United States.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samantha Meltzer-Brody Research Topics

Disease

34	Postpartum Depression (Post-Natal Depression) 03/2022 - 04/2007
6	Mood Disorders (Mood Disorder) 01/2020 - 01/2009
5	Bipolar Disorder (Manic Depressive Psychosis) 01/2018 - 12/2014
5	Wounds and Injuries (Trauma) 01/2017 - 02/2011
4	Mental Disorders (Mental Disorder) 01/2022 - 03/2016
3	Major Depressive Disorder (Major Depressive Disorders) 05/2020 - 12/2014
3	Pain (Aches) 11/2017 - 02/2011
2	Dizziness (Lightheadedness) 01/2018 - 01/2017
2	Sleepiness 01/2018 - 01/2017
1	COVID-19 03/2022
1	Confusion (Bewilderment) 01/2021
1	Pancreatitis 01/2021
1	Headache (Headaches) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Pregnancy Complications 01/2018
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018
1	Schizophrenia (Dementia Praecox) 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Sinus Tachycardia 01/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2017
1	Tension-Type Headache (Tension Headache) 01/2017
1	Substance-Related Disorders (Drug Abuse) 03/2016
1	Acute Pain 09/2012
1	Opioid-Related Disorders (Opiate Addiction) 09/2012
1	Dyspareunia 02/2011
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 02/2011
1	Dysmenorrhea (Menstrual Pain) 02/2011
1	Chronic Pain 02/2011
1	Pelvic Pain 02/2011
1	Familial Primary Pulmonary Hypertension 09/2009
1	Neonatal Abstinence Syndrome 09/2009
1	Serotonin Syndrome (Syndrome, Serotonin) 05/2005

Drug/Important Bio-Agent (IBA)

24	Tuberculin (PPD)IBA 01/2022 - 05/2009
8	brexanoloneIBA 01/2022 - 01/2017
6	Pregnanolone (Allopregnanolone)IBA 10/2020 - 01/2017
4	Antidepressive Agents (Antidepressants)IBA 01/2022 - 09/2009
4	Hormones (Hormone)IBA 01/2020 - 02/2015
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
2	NeurosteroidsIBA 10/2020 - 01/2020
2	SteroidsIBA 01/2020 - 01/2009
2	Oxytocin (Pitocin)FDA LinkGeneric 01/2020 - 01/2017
2	Aminobutyrates (Aminobutyric Acid)IBA 01/2018 - 01/2017
2	Progesterone FDA LinkGeneric 01/2018 - 01/2017
2	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2017 - 01/2017
1	SolutionsIBA 03/2022
1	neodymium pyrocatechin disulfonate (NPD)IBA 01/2022
1	zuranoloneIBA 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2020
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	BuffersIBA 01/2019
1	LithiumIBA 01/2018
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2017
1	Anti-Anxiety Agents (Anxiolytics)IBA 05/2017
1	Indicators and Reagents (Reagents)IBA 05/2017
1	Biomarkers (Surrogate Marker)IBA 10/2016
1	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2016
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 02/2015
1	Buprenorphine (Subutex)FDA LinkGeneric 09/2012
1	Opioid Analgesics (Opioids)IBA 09/2012
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 02/2011
1	Corticotropin-Releasing HormoneIBA 01/2011
1	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2007
1	Clozapine (Clozaril)FDA LinkGeneric 05/2005
1	ziprasidone (Geodon)FDA Link 05/2005
1	Citalopram FDA LinkGeneric 05/2005

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2017
1	Wearable Electronic Devices 03/2022
1	Prenatal Care (Care, Prenatal) 03/2016
1	Perinatal Care 11/2009